Assembly and heterologous expression of the pholipomycin biosynthetic gene cluster
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [25]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    [Objective] To assemble a complete pholipomycin biosynthetic gene cluster (pho-BGC) based on the nosokomycin B2 biosynthetic gene cluster (noso-BGC) derived from Streptomyces lincolnensis NRRL2936, and activate pho-BGC through heterologous expression for production increase of pholipomycin using the screening of the chassis hosts.[Methods] Firstly, three genes moeA4, moeB4, and moeC4 were cloned from the genome of moenomycin producer Streptomyces ghanaensis ATCC 14672 and introduced into lincomycin gene cluster deletion strain JCK126, which yielded the recombinant strain LX19. The fermentation extract detection of LX19 showed that pho-BGC was silent in S. lincolnensis NRRL2936. Subsequently, the gene cassette carrying moeA4, moeB4, and moeC4 was inserted into noso-BGC by gene assembly, resulting in the plasmid pJQK572 containing the intact pho-BGC. Then, plasmid pJQK572 was introduced into Streptomyces coelicolor M1152, S. lividans SBT18, S. lividans LJ1018, and S. coelicolor M1446, which generated strains LX20, LX21, LX22, and LX23, respectively. Finally, the pholipomycin production ability of different recombinants was estimated by bioactivity analysis and UPLC-TOF MS of fermented extracts, and the chemical structure of pholipomycin was identified by ESI-MS2.[Results] The complete pho-BGC achieved heterogeneous expression in S. coelicolor M1152. Moreover, the yield of pholipomycin was increased by 20% in S. coelicolor M1446 (carrying four copies of the ΦC31-attB sites).[Conclusion] This study determined that pho-BGC was silent in S. lincolnensis by systematic fermentation assay. Then, plasmid pJQK572 containing the complete pho-BGC was constructed based on noso-BGC. The liquid-mass spectrometry for the fermented extracts of different pho-BGC heterogeneous hosts determined that pholipomycin was successfully synthesized in S. coelicolor M1152. Moreover, the yield of pholipomycin in strain LX23 was increased by 20% through multi-copy integration of pho-BGC. The successful construction and heterologous expression of pho-BGC laid a foundation for revealing the biosynthesis mechanism and increasing the yield of pholipomycin.

    Reference
    [1] Torikata A, Yoshikawa H, Katayama T, Arai M, Nakahara M, Kitano N. Pholipomycin, a new member of phosphoglycolipid antibiotics. III. Biological properties. The Journal of Antibiotics, 1977, 30(12):1060-1063.
    [2] Sauvage E, Terrak M. Glycosyltransferases and transpeptidases/penicillin-binding proteins:valuable targets for new antibacterials. Antibiotics, 2016, 5(1):12.
    [3] Yu JY, Cheng HJ, Wu HR, Wu WS, Lu JW, Cheng TJ, Wu YT, Fang JM. Structure-based design of bacterial transglycosylase inhibitors incorporating biphenyl, amine linker and 2-alkoxy-3-phosphorylpropanoate moieties. European Journal of Medicinal Chemistry, 2018, 150:729-741.
    [4] Brown ED, Wright GD. Antibacterial drug discovery in the resistance era. Nature, 2016, 529(7586):336-343.
    [5] Huo LJ, Hug JJ, Fu CZ, Bian XY, Zhang YM, Müller R. Heterologous expression of bacterial natural product biosynthetic pathways. Natural Product Reports, 2019, 36(10):1412-1436.
    [6] Liu R, Deng ZX, Liu TG. Streptomyces species:ideal chassis for natural product discovery and overproduction. Metabolic Engineering, 2018, 50:74-84.
    [7] Myronovskyi M, Rosenkränzer B, Nadmid S, Pujic P, Normand P, Luzhetskyy A. Generation of a cluster-free Streptomyces albus chassis strains for improved heterologous expression of secondary metabolite clusters. Metabolic Engineering, 2018, 49:316-324.
    [8] Gomez-Escribano JP, Bibb MJ. Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters. Microbial Biotechnology, 2011, 4(2):207-215.
    [9] Li L, Zheng GS, Chen J, Ge M, Jiang WH, Lu YH. Multiplexed site-specific genome engineering for overproducing bioactive secondary metabolites in actinomycetes. Metabolic Engineering, 2017, 40:80-92.
    [10] Peng QY, Gao GX, Lü J, Long QS, Chen XF, Zhang F, Xu M, Liu K, Wang YM, Deng ZX, Li ZY, Tao MF. Engineered Streptomyces lividans strains for optimal identification and expression of cryptic biosynthetic gene clusters. Frontiers in Microbiology, 2018, 9:3042.
    [11] Paget MS, Chamberlin L, Atrih A, Foster SJ, Buttner MJ. Evidence that the extracytoplasmic function sigma factor sigmaE is required for normal cell wall structure in Streptomyces coelicolor A3(2). Journal of Bacteriology, 1999, 181(1):204-211.
    [12] Wallhausser KH, Nesemann G, Prave P, Steigler A. Moenomycin, a new antibiotic. I. Fermentation and isolation. Antimicrob Agents Chemother (Bethesda), 1965, 5(1):734-736.
    [13] Meng ST, Wu H, Wang L, Zhang BC, Bai LQ. Enhancement of antibiotic productions by engineered nitrate utilization in actinomycetes. Applied Microbiology and Biotechnology, 2017, 101(13):5341-5352.
    [14] Zhao ZL, Shi T, Xu M, Brock NL, Zhao YL, Wang YM, Deng ZX, Pang XH, Tao MF. Hybrubins:bipyrrole tetramic acids obtained by crosstalk between a truncated undecylprodigiosin pathway and heterologous tetramic acid biosynthetic genes. Organic Letters, 2016, 18(3):572-575.
    [15] Bierman M, Logan R, O'Brien K, Seno ET, Nagaraja Rao R, Schoner BE. Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp.. Gene, 1992, 116(1):43-49.
    [16] Li L, Xu ZN, Xu XY, Wu J, Zhang Y, He XY, Zabriskie TM, Deng ZX. The mildiomycin biosynthesis:initial steps for sequential generation of 5-hydroxymethylcytidine, 5'-monophosphate and 5-hydroxymethylcytosine in Streptoverticillium rimofaciens ZJU5119. ChemBioChem, 2008, 9(8):1286-1294.
    [17] Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA. Practical Streptomyces genetics. Colney:John Innes Fundation, 2000:125-158.
    [18] Lü J, Long QS, Zhao ZL, Chen L, He WJ, Hong JL, Liu K, Wang YM, Pang XH, Deng ZX, Tao MF. Engineering the erythromycin-producing strain Saccharopolyspora erythraea HOE107 for the heterologous production of polyketide antibiotics. Frontiers in Microbiology, 2020, 11:593217.
    [19] Ostash B, Doud EH, Lin C, Ostash I, Perlstein DL, Fuse S, Wolpert M, Kahne D, Walker S. Complete characterization of the seventeen step moenomycin biosynthetic pathway. Biochemistry, 2009, 48(37):8830-8841.
    [20] Horbal L, Ostash B, Luzhetskyy A, Walker S, Kalinowski J, Fedorenko V. A gene cluster for the biosynthesis of moenomycin family antibiotics in the genome of teicoplanin producer Actinoplanes teichomyceticus. Applied Microbiology and Biotechnology, 2016, 100(17):7629-7638.
    [21] Eichhorn P, Aga DS. Characterization of moenomycin antibiotics from medicated chicken feed by ion-trap mass spectrometry with electrospray ionization. Rapid Communications in Mass Spectrometry, 2005, 19(15):2179-2186.
    [22] Demain AL, Sanchez S. Microbial drug discovery:80 years of progress. The Journal of Antibiotics, 2009, 62(1):5-16.
    [23] Myronovskyi M, Luzhetskyy A. Heterologous production of small molecules in the optimized Streptomyces hosts. Natural Product Reports, 2019, 36(9):1281-1294.
    [24] Li L, Liu XC, Jiang WH, Lu YH. Recent advances in synthetic biology approaches to optimize production of bioactive natural products in actinobacteria. Frontiers in Microbiology, 2019, 10:2467.
    [25] Ostash B, Walker S. Moenomycin family antibiotics:chemical synthesis, biosynthesis, and biological activity. Natural Product Reports, 2010, 27(11):1594-1617.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

LI Xing, HAN Shuting, MA Jingxian, TAO Meifeng, KANG Qianjin, BAI Linquan, DENG Zixin. Assembly and heterologous expression of the pholipomycin biosynthetic gene cluster. [J]. Acta Microbiologica Sinica, 2022, 62(1): 291-304

Copy
Share
Article Metrics
  • Abstract:465
  • PDF: 1646
  • HTML: 1326
  • Cited by: 0
History
  • Received:April 08,2021
  • Revised:May 19,2021
  • Online: January 06,2022
Article QR Code